viridicatumtoxin
- Product Name
- viridicatumtoxin
- CAS No.
- 39277-41-3
- Chemical Name
- viridicatumtoxin
- Synonyms
- NSC 159628;viridicatumtoxin;Spiro[2-cyclohexene-1,2'(1'H)-cyclopenta[de]naphthacene]-9'-carboxamide, 7',7'a,8',11',11'a,12'-hexahydro-5',6',7'a,10',11'a,12'-hexahydroxy-3'-methoxy-2,6,6-trimethyl-7',8'-dioxo-, (1R,7'aR,11'aR,12'R)-rel-(-)-
- CBNumber
- CB91382922
- Molecular Formula
- C30H31NO10
- Formula Weight
- 565.57
- MOL File
- 39277-41-3.mol
viridicatumtoxin Property
- Melting point:
- 235°C (rough estimate)
- Boiling point:
- 630.75°C (rough estimate)
- Density
- 1.3203 (rough estimate)
- refractive index
- 1.6310 (estimate)
- storage temp.
- Store at -20°C
- solubility
- DMF: Soluble; DMSO: Soluble; Ethanol: Soluble; Methanol: Soluble
- form
- A solid
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Danger
- Hazard statements
-
H301Toxic if swalloed
- Precautionary statements
-
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P321Specific treatment (see … on this label).
P330Rinse mouth.
P405Store locked up.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- 25480
- Product name
- Viridicatumtoxin
- Purity
- ≥98%
- Packaging
- 1mg
- Price
- $227
- Updated
- 2024/03/01
- Product number
- 25480
- Product name
- Viridicatumtoxin
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $954
- Updated
- 2024/03/01
- Product number
- V673905
- Product name
- Viridicatumtoxin
- Packaging
- 1mg
- Price
- $230
- Updated
- 2021/12/16
- Product number
- BIO0000728
- Product name
- VIRIDICATUMTOXIN
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $504.9
- Updated
- 2021/12/16
- Product number
- 2060DM
- Product name
- Viridicatumtoxin
- Packaging
- 5mg
- Price
- $1161
- Updated
- 2021/12/16
viridicatumtoxin Chemical Properties,Usage,Production
Description
Viridicatumtoxin in a mycotoxin originally isolated from Penicillium that has diverse biological activities, including antimicrobial, cytotoxic, and toxic properties. It inhibits the growth of B. subtilis, M. luteus, C. perfringens, B. fragilis, and methicillin-resistant S. aureus (MRSA; MICs = 0.39-1.56 μg/ml), as well as C. albicans, S. cerevisiae, M. racemosus, A. niger, and P. chrysogenum (MICs = 6.2-25 μg/ml), but has no activity against M. smegmatis, E. coli, K. pneumoniae, P. aeruginosa, or S. marcescens (MICs = >100 μg/ml). Viridicatumtoxin inhibits the production of polyprenyl alcohols by S. aureus undecaprenyl pyrophosphate (UPP) synthase, E. coli octaprenyl pyrophosphate synthase (OPS), and S. cerevisiae dehydrodolichyl pyrophosphate (DedoIPP) synthase in vitro (IC50s = 3.1, 21, and 71 μM, respectively). It has cytotoxic effects against human Jurkat T (IC50 = 4.92 μM), chronic lymphocytic leukemia (CLL; LC50 = 0.7-3.5 nM), and bone marrow-derived HS-5 stromal cells. Viridicatumtoxin is toxic to rats and mice when administered intraperitoneally (LD50s = 80 and 90 mg/kg, respectively) and to rats when administered via gastric intubation (LD50 = 122.4 mg/kg), but not to rats or mice when administered orally or through subcutaneous injection.
Uses
Viridicatumtoxin is a tetracycline-like metabolite produced by several species of Penicillium, first isolated in 1976 as a mycotoxin. Initial testing revealed that viridicatumtoxin caused myocardial deterioration, renal tubule necrosis and spleen atrophy. Analogous to the related tetracyclines, viridicatumtoxin was found to be a potent antibacterial, with activity against S. aureus including MRSA and QRSA strains. Little has been published on the mode of action of viridicatumtoxin.
Uses
Viridicatumtoxin is a tetracycline-like metabolite produced by several species of Penicillium.
Definition
ChEBI: A tetracycline-like polyketide antibiotic that is produced by several species of Penicillium and Aspergillus.